InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Burnell Thomas W., Chief Executive Officer. Officer active across 1 companies, notably Interpace Biosciences, INC.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €154k. The latest transaction was disclosed on 21 May 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€77,07010,855 shares@ €7.10100.0% of flow
Common Stock
SEC:0001493152-21-012889·
Ideal exit: 15 Feb 2022 (T+270)
€77,07010,855 shares@ €7.100.16% mcap50.0% of flow
Common Stock
SEC:0001493152-21-012889:0·
Ideal exit: 15 Feb 2022 (T+270)
2 of 2 declarations
About Burnell Thomas W.
Thomas W. Burnell is the President & CEO at INTERPACE BIOSCIENCES, INC. He is responsible for the overall direction of the company, overseeing operations and strategy. His leadership is essential to ensure the growth and success of the organization.
